Healthcare Trust of America (NYSE: HTA) announced its financial results for Q4 2021 will be reported on February 23, 2022, after market close. A conference call is scheduled for February 24, 2022, at 11:00 a.m. ET to discuss the results. HTA is a leading owner and operator of medical office buildings in the U.S., with approximately 25.8 million square feet of gross leasable area and $7.7 billion invested in healthcare properties as of September 30, 2021. The company focuses on strategic markets to ensure long-term demand for quality medical office space.
Summary not available.
Healthcare Trust of America (NYSE: HTA) reported strong financial results for Q3 and the first nine months of 2021. Net income reached $0.10 per diluted share, while Funds From Operations (FFO) increased by 41.9% to $0.44 per share compared to Q3 2020. Year-to-date, net income totaled $81.7 million, or $0.37 per share. The company executed leases of 670,000 square feet in Q3 and projects full-year investment activity exceeding $400 million. HTA’s Board is evaluating strategic options to enhance shareholder value. A quarterly dividend of $0.325 per share was announced.
Healthcare Trust of America (HTA) will announce its financial results for Q3 2021 on November 5, 2021, prior to market opening. A conference call to discuss the results is scheduled for the same day at 11:30 a.m. Eastern Time. HTA, the largest owner and operator of medical office buildings in the U.S., has invested approximately $7.5 billion in real estate assets. The company focuses on essential market locations and aims to create value through high tenant retention and strategic partnerships.
Healthcare Trust of America (NYSE:HTA) announced a quarterly dividend of $0.325 per share, marking an annualized rate of $1.30 and a yield of 3.9% based on the closing share price as of November 3, 2021. The dividend will be paid on January 11, 2022 to stockholders of record on January 4, 2022. HTA is the largest owner and operator of medical office buildings, with investments totaling $7.5 billion across 25.3 million square feet of GLA in the U.S.
Summary not available.
Healthcare Trust of America, Inc. (NYSE: HTA) will report its financial results for Q3 2021 on November 4, 2021, after market closure. A conference call is scheduled for November 5, 2021, at 11:30 a.m. ET to discuss the results. The company invests approximately $7.5 billion in medical office buildings across the U.S., totaling around 25.3 million square feet. HTA focuses on strategic markets for healthcare services, aiming for high tenant retention and rental growth.
Healthcare Trust of America, Inc. (NYSE: HTA) responded to a letter from Elliott Investment Management, affirming its commitment to shareholder value. HTA's Board and management engaged in discussions with Elliott to explore their views, ensuring these insights were shared with the entire Board. The company emphasizes its focus on strategic planning to enhance shareholder returns. J.P. Morgan is serving as financial advisor, while McDermott Will & Emery LLP provides legal counsel. HTA is the largest owner/operator of medical office buildings in the U.S., with approximately 25.3 million square feet and $7.5 billion invested as of June 30, 2021.
Elliott Investment Management, a significant investor in Healthcare Trust of America (HTA), urged the Company's Board to conduct a strategic review due to HTA's long-term underperformance and uncompetitive cost of capital. Elliott believes a sale at a premium valuation is preferable to a standalone growth strategy. The firm is confident that credible buyers will offer substantial premiums, especially following the recent resignation of HTA’s CEO, Scott Peters. Elliott emphasizes that a transparent strategic review is essential for maximizing shareholder value and attracting a strong new CEO.
Healthcare Trust of America (HTA) has announced a new $1.3 billion Revolving Credit and Term Loan Agreement that refinances its previous unsecured credit. The arrangement consists of a $1 billion revolving credit facility and a $300 million term loan, both set to mature in October 2025. This agreement is expected to lower borrowing costs, with the Revolver priced at LIBOR plus 105 bps and the Term Loan at LIBOR plus 95 bps. Notably, the Credit Agreement includes sustainability-linked pricing adjustments based on the Company's sustainability ratings.